Clinical Trials Directory

Trials / Completed

CompletedNCT01731067

Cocktail Approach for Cytochrome P450 and P-glycoprotein Activity Assessment Using Dried Blood Spot

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Jules Desmeules · Academic / Other
Sex
Male
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Phenotyping is an approach largely used for the evaluation of the activity of cytochromes and transporters in vivo. It consists of the administration of probe substances metabolised by a specific cytochrome or transported by P-glycoprotein (P-gp) for example, followed by the determination of a metabolic ratio or the evaluation of the plasmatic or urinary concentrations of the probe substances. The administration of a cocktail containing several probe substances allows the simultaneous evaluation of the activity of several cytochromes and P-gp in a single test. The aim of this project is the validation of a phenotyping cocktail of low dose probe drugs for the assessment of cytochrome P450 and P-gp activities by simple capillary blood sampling and dried blood spot (DBS) analysis. The cocktail consists of caffeine, bupropion, flurbiprofen, omeprazole, dextromethorphan, midazolam and fexofenadine for the simultaneous phenotyping of CYP1A2, CYP2B6, CYP2C9, CAP2C19, CYP2D6, CYP3A4 and P-gp, respectively. The modulation of the activity of cytochromes or P-gp will be evaluated by the administration of inhibitors (fluvoxamine, voriconazole, quinidine) or inducer (rifampicin) of the metabolic pathways or the P-gp mediated transport.

Conditions

Interventions

TypeNameDescription
DRUGCocktail probe drugs

Timeline

Start date
2012-11-01
Primary completion
2013-05-01
Completion
2014-01-01
First posted
2012-11-21
Last updated
2014-09-16

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01731067. Inclusion in this directory is not an endorsement.